Aehr Test Systems (AEHR) is trading down at $61.99 (-2.12%), as of the latest quote. It is a Russell 2000 constituent in the Information Technology sector.
| FY2017May 2017 | FY2018May 2018 | FY2019May 2019 | FY2020May 2020 | FY2021May 2021 | FY2022May 2022 | FY2023May 2023 | FY2024May 2024 | FY2025May 2025 | FY2026May 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $18.9M | $29.6M | $21.1M | $22.3M | $16.6M | $50.8M | $65.0M | $66.2M | $59.0M | $50.0M |
| Growth (year over year) | +30.3% | +56.4% | −28.8% | +5.9% | −25.5% | +206.2% | +27.8% | +1.9% | −10.9% | −15.2% |
| Gross profit | $6.78M | $12.4M | $7.60M | $8.37M | $6.03M | $23.7M | $32.7M | $32.5M | $23.9M | $17.7M |
| Gross margin | 35.9% | 41.9% | 36.1% | 37.6% | 36.3% | 46.6% | 50.4% | 49.1% | 40.6% | 35.3% |
| Operating income | −$4.93M | $915.0K | −$5.00M | −$2.77M | −$4.18M | $7.80M | $13.4M | $10.1M | −$5.68M | −$14.1M |
| Operating margin | −26.1% | 3.1% | −23.7% | −12.4% | −25.2% | 15.3% | 20.6% | 15.2% | −9.6% | −28.3% |
| Net income | −$5.65M | $528.0K | −$5.24M | −$2.80M | −$2.03M | $9.45M | $14.6M | $33.2M | −$3.91M | −$7.13M |
| Net margin | −29.9% | 1.8% | −24.9% | −12.6% | −12.2% | 18.6% | 22.4% | 50.1% | −6.6% | −14.3% |
| EPS (diluted) | −$0.35 | $0.02 | −$0.23 | −$0.12 | −$0.09 | $0.34 | $0.50 | $1.12 | −$0.13 | −$0.23 |
| Balance sheet | ||||||||||
| Cash and equivalents | $17.8M | $16.8M | $5.43M | $5.43M | $4.58M | $31.5M | $30.1M | $49.2M | $24.5M | $116.4M |
| Total assets | $30.9M | $31.0M | $21.3M | $20.6M | $21.7M | $62.3M | $98.1M | $127.9M | $148.5M | $246.7M |
| Total liabilities | $14.1M | $11.7M | $5.85M | $6.52M | $10.2M | $11.3M | $22.5M | $16.3M | $25.6M | $27.2M |
| Long-term debt | $6.11M | $0 | $0 | $1.03M | $0 | — | — | — | — | — |
| Shareholders' equity | $16.8M | $19.3M | $15.5M | $14.1M | $11.4M | $51.0M | $75.6M | $111.6M | $122.9M | $219.5M |
| Cash flow | ||||||||||
| Operating cash flow | −$4.50M | −$1.35M | −$5.64M | −$2.02M | −$2.70M | $1.51M | $10.0M | $1.76M | −$7.40M | −$3.31M |
| Capital expenditure | $477.0K | $572.0K | $173.0K | $163.0K | $227.0K | $416.0K | $1.36M | $749.0K | $4.99M | $2.07M |
| Free cash flow | −$4.97M | −$1.92M | −$5.81M | −$2.19M | −$2.93M | $1.09M | $8.65M | $1.01M | −$12.4M | −$5.38M |
| Q1 FY25Aug 2024 | Q2 FY25Nov 2024 | Q3 FY25Feb 2025 | Q4 FY25†May 2025 | Q1 FY26Aug 2025 | Q2 FY26Nov 2025 | Q3 FY26Feb 2026 | Q4 FY26†May 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $13.1M | $13.5M | $18.3M | $14.1M | $11.0M | $9.88M | $10.3M | $18.8M |
| Growth (year over year) | −36.4% | −37.2% | +142.1% | −15.1% | −16.4% | −26.5% | −43.7% | +33.7% |
| Gross profit | $7.08M | $5.40M | $7.18M | $4.27M | $3.72M | $2.54M | $3.37M | $8.02M |
| Gross margin | 54.0% | 40.1% | 39.2% | 30.3% | 33.9% | 25.7% | 32.7% | 42.6% |
| Operating income | $159.0K | −$1.51M | −$1.12M | −$3.20M | −$4.07M | −$4.65M | −$4.23M | −$1.21M |
| Operating margin | 1.2% | −11.2% | −6.1% | −22.7% | −37.1% | −47.0% | −41.0% | −6.4% |
| Net income | $660.0K | −$1.03M | −$643.0K | −$2.90M | −$2.08M | −$3.23M | −$3.20M | $1.39M |
| Net margin | 5.0% | −7.6% | −3.5% | −20.6% | −19.0% | −32.7% | −31.1% | 7.4% |
| EPS (diluted) | $0.02 | −$0.03 | −$0.02 | −$0.10 | −$0.07 | −$0.11 | −$0.10 | $0.05 |
| Balance sheet | ||||||||
| Cash and equivalents | $37.8M | $32.2M | $29.4M | $24.5M | $22.7M | $30.8M | $36.9M | $116.4M |
| Total assets | $145.9M | $142.3M | $145.6M | $148.5M | $144.1M | $148.7M | $157.0M | $246.7M |
| Total liabilities | $23.4M | $19.1M | $21.4M | $25.6M | $21.7M | $18.0M | $18.3M | $27.2M |
| Shareholders' equity | $122.5M | $123.2M | $124.2M | $122.9M | $122.4M | $130.8M | $138.8M | $219.5M |
| Cash flow | ||||||||
| Operating cash flow | $2.38M | −$5.87M | −$1.60M | −$2.30M | −$282.0K | −$1.17M | −$3.69M | $1.83M |
| Capital expenditure | $197.0K | $321.0K | $1.66M | $2.82M | $1.39M | $467.0K | $74.0K | $134.0K |
| Free cash flow | $2.18M | −$6.19M | −$3.26M | −$5.12M | −$1.67M | −$1.64M | −$3.76M | $1.70M |
From Aehr Test Systems's 10-K and 10-Q filings with the SEC; its fiscal year ends in May. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Aehr Test Systems shareholders elect directors and approve proposals at annual meeting
Aehr Test Systems shareholders elect directors and approve proposals at annual meeting
Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation
Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation
Aehr Test Systems Sinks 10%, Teradyne Falls 5%, FormFactor Drops 6%: What’s Hitting These Semiconductor Test Equipment Stocks?
Aehr Test Systems Sinks 10%, Teradyne Falls 5%, FormFactor Drops 6%: What’s Hitting These Semiconductor Test Equipment Stocks?